The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
M-CSF mediates TNF-induced inflammatory osteolysis
Open accessAbstract
TNF-alpha is the dominant cytokine in inflammatory osteolysis. Using mice whose BM stromal cells and osteoclast precursors are chimeric for the presence of TNF receptors, we found that both cell types mediated the cytokine's osteoclastogenic properties. The greater contribution was made, however, by stromal cells that express the osteoclastogenic cytokine M-CSF. TNF-alpha stimulated M-CSF gene expression, in vivo, only in the presence of TNF-responsive stromal cells. M-CSF, in turn, induced the key osteoclastogenic cytokine receptor, receptor activator of NF-kappaB (RANK), in osteoclast precursors. In keeping with the proproliferative and survival properties of M-CSF, TNF-alpha enhanced osteoclast precursor number only in the presence of stromal cells bearing TNF receptors. To determine the clinical relevance of these observations, we induced inflammatory arthritis in wild-type mice and treated them with a mAb directed against the M-CSF receptor, c-Fms. Anti-c-Fms mAb selectively and completely arrested the profound pathological osteoclastogenesis attending this condition, the significance of which is reflected by similar blunting of the in vivo bone resorption marker tartrate-resistant acid phosphatase 5b (TRACP 5b). Confirming that inhibition of the M-CSF signaling pathway targets TNF-alpha, anti-c-Fms also completely arrested osteolysis in TNF-injected mice with nominal effect on macrophage number. M-CSF and its receptor, c-Fms, therefore present as candidate therapeutic targets in states of inflammatory bone erosion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,228
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Lam, J., Takeshita, S., Barker, J. E., Kanagawa, O., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11176 · Cited by 1,440 · cited 5×
“This molecule, which is produced in abundance in bone erosive diseases such as rheumatoid arthritis and periodontitis (5–9), profoundly accelerates the osteoclastogenic process (10).”
BackgroundInfluentialSelf-citationAnti-TNFα Therapy of Rheumatoid Arthritis: What Have We Learned?
Feldmann, M., & Maini, R. N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.163 · Cited by 1,257
Dai, X.-M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., & Stanley, E. R. (2002) · Blood · doi:10.1182/blood.v99.1.111 · Cited by 1,184 · cited 1×
“The transmembrane tyrosine kinase, c-Fms, is the sole M-CSF receptor (23, 24), and deletion of its gene leads to the same phenotype as the op/op mouse (25).”
BackgroundLi, J., Sarosi, I., Yan, X.-Q., Morony, S., Capparelli, C., Tan, H.-L., McCabe, S., Elliott, R., Scully, S., Van, G., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1566 · Cited by 1,119 · cited 1×
“Thus, inflammatory osteolysis does not occur in RANK-deficient mice (11, 12).”
BackgroundUdagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T. J., & Suda, T. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7260 · Cited by 1,048
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W., Ahmed-Ansari, A., Sell, K. W., Pollard, J. W., & Stanley, E. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.12.4828 · Cited by 1,031 · cited 1×
“This animal, which bears a point mutation in the Csf1 gene coding for M-CSF, is born osteopetrotic due to failure to generate osteoclasts and is rescued by the cytokine (22).”
BackgroundTherapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Organ-Specific Disease Provoked by Systemic Autoimmunity
Kouskoff, V., Korganow, A.-S., Duchatelle, V., Degott, C., Benoist, C., & Mathis, D. (1996) · Cell · doi:10.1016/s0092-8674(00)81989-3 · Cited by 892
IL-1 mediates TNF-induced osteoclastogenesis
Wei, S., Kitaura, H., Zhou, P., Ross, F. P., & Teitelbaum, S. L. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523394 · Cited by 795
Self-citationBekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2004) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.040305 · Cited by 771
From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins
Korganow, A.-S., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J.-L., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 690
Ritchlin, C. T., Haas-Smith, S. A., Li, P., Hicks, D. G., & Schwarz, E. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16069 · Cited by 616
Genovese, M. C., Cohen, S., Moreland, L., Lium, D., Robbins, S., Newmark, R., Bekker, P., & for the 20000223 Study Group (2004) · Arthritis & Rheumatism · doi:10.1002/art.20221 · Cited by 532
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J.-P., Tohidast-Akrad, M., Kollias, G., Steiner, G., Smolen, J. S., Wagner, E. F., & Schett, G. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15582 · Cited by 531
Niida, S., Kaku, M., Amano, H., Yoshida, H., Kataoka, H., Nishikawa, S., Tanne, K., Maeda, N., Nishikawa, S.-I., & Kodama, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.293 · Cited by 444
Romas, E., Gillespie, M. T., & Martin, T. J. (2002) · Bone · doi:10.1016/s8756-3282(01)00682-2 · Cited by 411
Gravallese, E. M. (2002) · Annals of the Rheumatic Diseases · doi:10.1136/ard.61.suppl_2.ii84 · Cited by 328
Zwerina, J., Hayer, S., Tohidast‐Akrad, M., Bergmeister, H., Redlich, K., Feige, U., Dunstan, C., Kollias, G., Steiner, G., Smolen, J., et al. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11487 · Cited by 307
Murray, L. J., Abrams, T. J., Long, K. R., Ngai, T. J., Olson, L. M., Hong, W., Keast, P. K., Brassard, J. A., O'Farrell, A. M., Cherrington, J. M., et al. (2003) · Clinical & Experimental Metastasis · doi:10.1023/b:clin.0000006873.65590.68 · Cited by 305
Srivastava, S., Weitzmann, M. N., Kimble, R. B., Rizzo, M., Zahner, M., Milbrandt, J., Ross, F. P., & Pacifici, R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4561 · Cited by 202
Tumor Necrosis Factor Receptors Types 1 and 2 Differentially Regulate Osteoclastogenesis
Abu-Amer, Y., Erdmann, J., Alexopoulou, L., Kollias, G., Ross, F. P., & Teitelbaum, S. L. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61511-5 · Cited by 195
c-Fms and the αvβ3 integrin collaborate during osteoclast differentiation
Faccio, R., Takeshita, S., Zallone, A., Ross, F. P., & Teitelbaum, S. L. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16924 · Cited by 194
Kitaura, H., Sands, M. S., Aya, K., Zhou, P., Hirayama, T., Uthgenannt, B., Wei, S., Takeshita, S., Novack, D. V., Silva, M. J., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.4838 · Cited by 190 · cited 10×
“T cells were eliminated in vivo during the course of the experiment by injection of anti-CD4 and anti-CD8 mAbs (15).”
BackgroundMethodInfluentialSelf-citationFunctional hierarchy of c-kit and c-fms in intramarrow production of CFU-M.
Sudo, T., Nishikawa, S., Ogawa, M., Kataoka, H., Ohno, N., Izawa, A., Hayashi, S., & Nishikawa, S. (1995) · PubMed · Cited by 167
Bekker, P. J., Holloway, D. L., Rasmussen, A. S., Murphy, R., Martin, S. W., Leese, P. T., Holmes, G. B., Dunstan, C. R., & DePaoli, A. M. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2005.20.12.2274 · Cited by 113
Myint, Y. Y., Miyakawa, K., Naito, M., Shultz, L. D., Oike, Y., Yamamura, K., & Takahashi, K. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65301-1 · Cited by 63
High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.
Takei, I., Takagi, M., Ida, H., Ogino, T., Santavirta, S. S., & Konttinen, Y. T. (2000) · PubMed · Cited by 55
Inhibition of c-fms by Imatinib: Expanding the Spectrum of Treatment
Dewar, A. L., Zannettino, A. C. W., Hughes, T. P., & Lyons, A. B. (2005) · Cell Cycle · doi:10.4161/cc.4.7.1788 · Cited by 54
Osteoclasts are essential for TNF-α–mediated joint destruction
Redlich, K., Hayer, S., Ricci, R., David, J., Tohidast-Akrad, M., Kollias, G. A., Steiner, G. E., Smolen, J. S., Wagner, E. F., & Schett, G. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200215582 · Cited by 35
Macrophage colony-stimulating factor in patients with rheumatoid arthritis.
Kawaji, H., Yokomuro, K., Kikuchi, K., Somoto, Y., & Shirai, Y. (1995) · Journal of Nippon Medical School · doi:10.1272/jnms1923.62.260 · Cited by 29
Regulation of CYL /Cyclin D Genes by Colony‐Stimulating Factor 1
Sherr, C. J., Matsushime, H., & Roussel, M. F. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514320.ch13 · Cited by 24
Macrophage Colony Stimulating Factor [CSF-1]
Lotze, M. T., & HAMILTON, J. (2003) · Elsevier eBooks · doi:10.1016/b978-012689663-3/50044-2 · Cited by 8
(1997) · doi:10.1002/(sici)1098-2795(199701)46:1<4::aid-mrd2>3.0.co;2-v
Cited by
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Tracey, D., Klareskog, L., Sasso, E. H., Salfeld, J. G., & Tak, P. P. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.10.001 · Cited by 1,628
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
“In collagen-induced arthritis and another mouse model of arthritis, there was no effect on paw swelling (and therefore the inflammatory process), but a preferential effect on joint integrity, using an M-CSF-receptor-specific antibod”
BackgroundPlatelets, inflammation and tissue regeneration
Nurden, A. (2011) · Thrombosis and Haemostasis · doi:10.1160/ths10-11-0720 · Cited by 791
Osteoclasts: What Do They Do and How Do They Do It?
Teitelbaum, S. L. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060834 · Cited by 730
“Interestingly, TNFalso promotes c-fms production, and the osteolysis of the inflamed joint is completely arrested by blocking the MCSF receptor.(37,43) In this regard, osteoclastogenesis may be pathologically increased by hypersensitivity to M-CSF.”
InfluentialOsteoimmunology: Interactions of the Bone and Immune System
Lorenzo, J., Horowitz, M., & Choi, Y. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0038 · Cited by 563
Metadata
- Authors
- Kitaura, H.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-12-01
- Volume
- 115
- Issue
- 12
- Pages
- 3418-3427
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1968796843
- Cited by
- 292
- References
- 36
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.